After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Puma CEO Alan Auerbach wanted the cash desperately, regardless of Puma's stock price. Get the deal done, even if you have to sell it to the shorts.
Puma Biotechnology (PBYI) is commencing a secondary public offering of stock.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
Shares are finally roaring back from big losses in 2014 and 2015.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.